Proteasomes are involved in many regulatory and metabolic processes [8, 9, 10]. It has been shown that the proteasome itself can participate in the extraction of an ER-membrane protein from the lipid bilayer. Nevertheless, mechanistic details of how the proteasome may attack and digest immobilized substrates are largely unknown.
The aim of this study is to develop an in vitro assay to study the degradation of oligomeric peptide substrates
that are immobilized by covalent attachment to various types of solid surfaces.
We are using a pp89-derived 25-meric peptide from cytomegalo virus (Kloe411) in the solid-phase
and the 20S proteasome isolated from erythrocytes. Proteolytic fragments are identified by mass spectroscopy.
The fragment pattern obtained with the immobilized substrate is being compared with cleavage patterns generated with the soluble one.
Finally, we should be able to generate a kinetic model from the fragment pattern.
Researchers
Marc Hovestädt
Prof. Hermann-Georg Holzhütter
in cooperation with the Molecular Libraries and Recognition Group,
Dr. Rudolf Volkmer, Charité - Universitätsmedizin Berlin, Institute for Medical Immunology
and Ulrike Kuckelkorn from Prof. Kloetzel’s group, Charité - Universitätsmedizin Berlin,
Institute of Biochemistry
References
[1] Frank R. (1992)
Spot synthesis an easy technique for positionally addressable, parallel chemical synthesis on a membrane support.
Tetrahedron 48(42), 9217-9232
[Abstract]
[2] Wenschuh et al. (2000)
Positionally adressable parallel synthesis on continuous membranes.
Combinatorial Chemistry, A Practical Approach, Oxford University Press. ISBN 0 19 963754 7.
[3] Reineke, U., et al., Applications of peptide arrays prepared by the SPOT-technology. Curr Opin Biotechnol 12, 59-64 (2001).
[4] Bhargava, S., et al., A complete substitutional analysis of VIP for better tumor imaging properties. J Mol Recognit 15, 145-153 (2002).
[5] Kamradt, T., et al.., Cross-reactivity of T lymphocytes in infection and autoimmunity. Mol. Div. 8, 271-280, (2004)
[6] Paston, S. J. et al., Hum Immunol, 65, 544-9, (2004).
[7] Elkington, R. et al., Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 2003, 77, 5226-40 -
[8] Diamond, D. J. et al., Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 1997, 90, 1751-67
[9] Ay, B.; Streitz, M.; Boisguerin, P.; Schlosser, A.; Mahrenholz, C. C.; Schuck, S. D.; Kern, F.; Volkmer, R., Sorting and pooling strategy: A novel tool to map a virus proteome for CD8 T-cell epitopes. Biopolymers 2007, 88, (1), 64-75.
[10] Ay, B.; Volkmer, R.; Boisguerin, P., Synthesis of cleavable peptides with authentic C-termini: an application for fully automated SPOT synthesis. Tetrahedron Letters 2007, 48, (3), 361-364